STOCK TITAN

Revitalist Appoints Dr. Denise Hopkins-Chadwick as Senior Vice President of Research

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary

Revitalist Lifestyle and Wellness Ltd. announced the appointment of Dr. Denise Hopkins-Chadwick as Senior Vice President of Research. With over 35 years of experience, Dr. Hopkins-Chadwick will lead R&D efforts, focusing on achieving funding goals and securing grants. CEO Kathryn Walker expressed excitement about her joining, emphasizing her impactful background in healthcare research and grant writing, having secured over $50 million in funding. Revitalist continues its mission to enhance well-being through innovative treatments and services across the U.S.

Positive
  • Appointment of Dr. Denise Hopkins-Chadwick as SVP of Research expected to enhance R&D leadership.
  • Dr. Hopkins-Chadwick brings extensive experience, including securing over $50 million in research funding.
Negative
  • Potential concerns about continuity in R&D leadership due to the recent management change.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to announce the appointment of Dr. Denise Hopkins-Chadwick, PhD RN, Retired US Army Colonel, as Senior Vice President of Research (“R&D”).

Kathryn Walker, CEO, commented, "On behalf of the team at Revitalist, I am very excited to welcome Denise to the company. As Revitalist continues to grow, we are pleased to have someone of Denise’s caliber and experience lead R&D in our organization. Denise will be pivotal in achieving our ambitious funding goals and securing grants to further the mission of Revitalist.”

Denise Hopkins-Chadwick received her PhD from the Ohio State University in Columbus, Ohio and has over 35 years of experience writing grants and working with patients, research participants, families, and faculty. Denise is a 30-year active-duty veteran Commissioned Officer in the Nurse Corps with clinical background experience spanning adults to neonatal ICUs, Emergency departments and patient transport. She serves on multiple boards including the Military Medicine Journal and the Tri-Service Nursing Research Interest Group: Women’s Health. Throughout her career, she has received dozens of awards in healthcare research and has secured research funding of over $50 million. She is Co-Inventor of the Precision Health Insight Tool which integrates data from multiple sources including behavioral health and pharmaceuticals into a unified system. Denise is also the founder of HC Research Associates, a company providing professional R&D as well as academic activities.

Dr. Denise Hopkins-Chadwick, commented, “I could not be happier about joining Revitalist and look forward to working with the team as we embark on the research and development of transformative programs which have a positive impact on patients and their families.”

ABOUT REVITALIST LIFESTYLE AND WELLNESS LTD.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided thousands of infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. For additional information and to be added to the Company’s mailing list, please click here.

Twitter:

@RevitalistCorp

 

Facebook:

@RevitalistLifestyleandWellnessLtd.

 

Instagram:

@RevitalistCorp

 

LinkedIn:

@RevitalistLifestyleAndWellnessLtd

 

On Behalf of the Board
Kathryn Walker
Chief Executive Officer

Forward Looking Statements

This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.

Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Revitalist Lifestyle and Wellness Ltd.

Email: IR@revitalist.com

Tel: (865) 585-8414

Source: Revitalist Lifestyle and Wellness Ltd.

FAQ

What does the appointment of Dr. Denise Hopkins-Chadwick mean for RVLWF?

Dr. Hopkins-Chadwick's appointment is expected to strengthen the research and development efforts at Revitalist, potentially leading to improved funding and innovative treatments.

What experience does Dr. Denise Hopkins-Chadwick bring to Revitalist?

Dr. Hopkins-Chadwick has over 35 years of experience in healthcare research and grant writing, including securing more than $50 million in funding.

When was Dr. Denise Hopkins-Chadwick appointed at Revitalist?

Dr. Denise Hopkins-Chadwick was appointed as Senior Vice President of Research in the recent press release dated January 25, 2022.

What are the expectations for Revitalist with Dr. Hopkins-Chadwick onboard?

With Dr. Hopkins-Chadwick leading R&D, Revitalist aims to achieve ambitious funding goals and enhance its research capabilities.

REVITALIST LIFESTYLE WLNS

OTC:RVLWF

RVLWF Rankings

RVLWF Latest News

RVLWF Stock Data

3.10M
135.04M
1.82%
Medical Care Facilities
Healthcare
Link
United States of America
Vancouver